The APP/PS1 mice treated with either dose of AZ59 showed a nonsignificant trend to spend more time in the target quadrant than did APP/PS1 mice treated with control IgG and were not significantly different from WT mice.
← all excerpts
Anti-PrP<sup>C</sup> antibody rescues cognition and synapses in transgenic alzheimer mice.
1
—
—